Dissection of Signal Transduction Pathways as a Tool for the Development of Targeted Therapies of Hepatocellular Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|2|3|217-236

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.2, Iss.3, 2007-09, pp. : 217-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 30-44

Karger

Access to resources Recommend Favorite

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Signaling Pathways in Hepatocellular Carcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies

By  

Current Signal Transduction Therapy, Vol. 5, Iss. 3, 2010-09 ,pp. : 231-236

Bentham Science Publishers

Access to resources Recommend Favorite